Please use this identifier to cite or link to this item:
|Title:||Anti-oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats||Authors:||Wasser, S.
Placental form of glutathione-S-transferase
Tissue inhibitor of metalloproteinase-1
Transforming growth factor-β1
|Issue Date:||2001||Citation:||Wasser, S., Lim, G.Y., Ong, C.-N., Tan, C.E.L. (2001). Anti-oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats. Journal of Gastroenterology and Hepatology (Australia) 16 (11) : 1244-1253. ScholarBank@NUS Repository. https://doi.org/10.1046/j.1440-1746.2001.02621.x||Abstract:||Background: Hepatic fibrosis occurs because of injury to the liver parenchyma and biliary system. We have investigated the effect of an organic selenium anti-oxidant, ebselen, in the resolution of experimentally induced hepatic fibrosis, and evaluated its effect on various paradigms involved in hepatic fibrosis. Methods: Following pretreatment with phenobarbitone, liver fibrosis was induced in male Fischer 344 rats by using carbon tetrachloride treatment for 10 weeks. Carbon tetrachloride-treated rats were randomly assigned into two groups: (i) no ebselen; and (ii) ebselen administered for 3 weeks following a 10-week carbon tetrachloride treatment period. Normal controls were: (i) neither carbon tetrachloride nor ebselen treated; or (ii) ebselen treated for 13 weeks. Liver sections were stained with hematoxylin and eosin, Masson trichrome and stained for reticulin by using silver impregnation. Reverse transcription-polymerase chain reaction was used to analyze the steady-state levels of gene(s) involved in: (i) hepatic fibrosis, namely, transforming growth factor-β1, procollagen I and III, tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-13; (ii) oxidative stress, namely, cytochrome P4502E1; and (iii) preneoplastic liver foci, namely, the placental form of glutathione-S-transferase. Results: Histological staining showed that ebselen resolves carbon tetrachloride-induced hepatic fibrosis. Treatment with ebselen reduced steady-state levels of transforming growth factor-β1, procollagen I and III, tissue inhibitor of metalloproteinase-1, cytochrome P4502E1 and placental form glutathione-S-transferase transcripts, and increased transcripts of matrix metalloproteinase-13. Conclusion: These findings provide evidence that ebselen significantly causes the resolution of carbon tetrachloride-induced hepatic fibrosis in rats. © 2001 Blackwell Science Asia Pty Ltd.||Source Title:||Journal of Gastroenterology and Hepatology (Australia)||URI:||http://scholarbank.nus.edu.sg/handle/10635/113366||ISSN:||08159319||DOI:||10.1046/j.1440-1746.2001.02621.x|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 23, 2023
WEB OF SCIENCETM
checked on Jan 23, 2023
checked on Jan 26, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.